Cargando…
Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lob...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918925/ https://www.ncbi.nlm.nih.gov/pubmed/1517147 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x |
_version_ | 1783317522751160320 |
---|---|
author | Shirai, Tomoyuki Iwasaki, Shogo Naito, Hatsumi Masui, Tsuneo Kato, Toshio Imaida, Katsumi |
author_facet | Shirai, Tomoyuki Iwasaki, Shogo Naito, Hatsumi Masui, Tsuneo Kato, Toshio Imaida, Katsumi |
author_sort | Shirai, Tomoyuki |
collection | PubMed |
description | Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lobe developed in a N‐OH‐DMAB dose‐dependent manner (0, 17.6 and 66.7%, respectively) with limited tumor yields in other organs. Although intraperitoneal administration of DMAB was similarly found to induce prostate tumors, it also caused severe chemical peritonitis, which resulted in a high mortality. The present data confirmed that intraperitoneal administration of N‐OH‐DMAB provides a relatively specific induction method for models of prostate carcinogenesis. |
format | Online Article Text |
id | pubmed-5918925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1992 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59189252018-05-11 Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis Shirai, Tomoyuki Iwasaki, Shogo Naito, Hatsumi Masui, Tsuneo Kato, Toshio Imaida, Katsumi Jpn J Cancer Res Article Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lobe developed in a N‐OH‐DMAB dose‐dependent manner (0, 17.6 and 66.7%, respectively) with limited tumor yields in other organs. Although intraperitoneal administration of DMAB was similarly found to induce prostate tumors, it also caused severe chemical peritonitis, which resulted in a high mortality. The present data confirmed that intraperitoneal administration of N‐OH‐DMAB provides a relatively specific induction method for models of prostate carcinogenesis. Blackwell Publishing Ltd 1992-07 /pmc/articles/PMC5918925/ /pubmed/1517147 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x Text en |
spellingShingle | Article Shirai, Tomoyuki Iwasaki, Shogo Naito, Hatsumi Masui, Tsuneo Kato, Toshio Imaida, Katsumi Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title | Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title_full | Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title_fullStr | Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title_full_unstemmed | Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title_short | Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis |
title_sort | dose dependence of n‐hydroxy‐3,2′‐dimethym‐aminobiphenyl‐induced rat prostate carcinogenesis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918925/ https://www.ncbi.nlm.nih.gov/pubmed/1517147 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x |
work_keys_str_mv | AT shiraitomoyuki dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis AT iwasakishogo dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis AT naitohatsumi dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis AT masuitsuneo dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis AT katotoshio dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis AT imaidakatsumi dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis |